Lucid Diagnostics Inc.
LUCD
$1.26
$0.086.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.16% | -17.28% | 15.10% | 49.68% | 513.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.16% | -17.28% | 15.10% | 49.68% | 513.84% |
| Cost of Revenue | -3.16% | -6.34% | 47.12% | 3.06% | 4.20% |
| Gross Profit | 37.30% | -10.38% | -126.79% | 39.84% | 54.10% |
| SG&A Expenses | 6.03% | 23.80% | 13.71% | 15.37% | 15.45% |
| Depreciation & Amortization | 0.00% | -109.03% | -64.71% | -79.21% | -79.21% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.11% | 12.91% | 7.84% | 8.02% | 3.62% |
| Operating Income | -1.72% | -15.71% | -7.18% | -5.09% | 3.38% |
| Income Before Tax | 59.66% | -153.56% | -6.57% | 12.93% | 3.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.66% | -153.56% | -6.57% | 12.93% | 3.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.66% | -153.56% | -6.57% | 12.93% | 3.30% |
| EBIT | -1.72% | -15.71% | -7.18% | -5.09% | 3.38% |
| EBITDA | -1.82% | -19.19% | -11.35% | -9.29% | -0.11% |
| EPS Basic | 65.09% | -30.13% | 22.71% | 27.64% | 16.10% |
| Normalized Basic EPS | 50.49% | 24.28% | 49.84% | 13.51% | 17.55% |
| EPS Diluted | 65.09% | -30.13% | 22.71% | 27.64% | 16.10% |
| Normalized Diluted EPS | 50.49% | 24.28% | 49.84% | 13.51% | 17.55% |
| Average Basic Shares Outstanding | 105.32% | 52.83% | 37.91% | 20.33% | 15.25% |
| Average Diluted Shares Outstanding | 105.32% | 52.83% | 37.91% | 20.33% | 15.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |